Derivative exercise or conversion — not an open-market buy.
Traded Apr 24, 2026 · Filed Apr 27, 2026
Globe Life's - Chief Strategy Officer sold $2.65M of Globe Life shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$2,651,268
Shares × reported transaction price
2 days after results of Apr 22, 2026, 89 days before results of Jul 22, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $152.56 on Apr 24, 2026, within 1% of its 52-week high, after a 10% rise over the previous 30 trading days
52-week range $117.60 (Jul 9, 2025) to $153.97 (Apr 23, 2026), 96% of the way up, from 251 adjusted closes. 30 trading days earlier: $138.77 on Mar 12, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Apr 30, 2024 in the U.S. District Court, E.D. Texas. A filing is an allegation, not a finding.
City of Miami General Employees' & Sanitation Employees' Retirement Trust v. Globe Life Inc., docket 4:24-cv-00376, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.0% | +1.7% | -0.7% |
| 30 days | +0.7% | +6.0% | -5.3% |
| 90 days | +14.2% | +3.9% | +10.4% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
58K → 50K shares held−14% of their stake
The money chief of Globe Life sold $1.24M of Globe Life shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.